Determination of the substrate repertoire of ADAMTS2, 3 and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF-beta signaling as primary targets.
Bekhouche, Mourad ; Université de Liège > Département des sciences biomédicales et précliniques > Laboratoire des tissus conjonctifs
Leduc, Cédric ; Université de Liège > Département des sciences biomédicales et précliniques > Laboratoire des tissus conjonctifs
Dupont, Laura ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Laboratoire de Biologie des Tissus Conjonctifs
Janssen, Lauriane; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Laboratoire de Biologie des Tissus Conjonctifs
Delolme, Frédéric; CNRS/University of LYON > Unté Mixte de Recherche 5305 et Unité mixte de Service 3444 > Tissue Biology and Therapeutic Engineering/Institute for the Biology and Chemistry of Proteins.
Vadon-Le Goff, Sandrine; CNRS/University of LYON > Unité mixte de recherche 5305 > Tissue Biology and Therapeutic Engineering
Smargiasso, Nicolas ; Université de Liège > Département de chimie (sciences) > Laboratoire de spectrométrie de masse (L.S.M.)
Determination of the substrate repertoire of ADAMTS2, 3 and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF-beta signaling as primary targets.
Publication date :
06 January 2016
Journal title :
FASEB Journal
ISSN :
0892-6638
eISSN :
1530-6860
Publisher :
Federation of American Society for Experimental Biology, Bethesda, United States - Maryland
Bekhouche, M., and Colige, A. (2015) The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology. Matrix Biol. 44-46, 46-53
Nusgens, B. V., Verellen-Dumoulin, C.,Hermanns-Lê, T.,De Paepe, A., Nuytinck, L., Piérard, G. E., and Lapière, C. M. (1992) Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. Nat. Genet. 1, 214-217
Li, S. W., Arita,M., Fertala, A., Bao, Y., Kopen, G. C., Långsjö, T. K., Hyttinen,M.M.,Helminen,H. J.,andProckop,D. J. (2001)Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility. Biochem. J. 355, 271-278
Hofer, T. P., Frankenberger, M., Mages, J., Lang, R., Meyer, P., Hoffmann, R., Colige, A., and Ziegler-Heitbrock, L. (2008) Tissuespecific induction of ADAMTS2 in monocytes and macrophages by glucocorticoids. J. Mol. Med. (Berl.) 86, 323-332
Arning, A., Hiersche, M., Witten, A., Kurlemann, G., Kurnik, K., Manner, D., Stoll,M., and Nowak-Göttl, U. (2012) A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric stroke. Blood 120, 5231-5236
Goertsches,R., Comabella, M.,Navarro,A., Perkal,H., andMontalban, X. (2005) Genetic association between polymorphisms in the ADAMTS14 gene andmultiple sclerosis. J. Neuroimmunol. 164, 140-147
Poonpet, T., Honsawek, S., Tammachote, N., Kanitnate, S., and Tammachote, R. (2013) ADAMTS14 gene polymorphismassociated with knee osteoarthritis in Thai women. Genet. Mol. Res. 12, 5301-5309
Rodriguez-Lopez, J., Pombo-Suarez, M., Loughlin, J., Tsezou, A., Blanco, F. J.,Meulenbelt, I., Slagboom, P. E.,Valdes,A. M., Spector, T. D., Gomez-Reino, J. J., and Gonzalez, A. (2009) Association of a nsSNP in ADAMTS14 to some osteoarthritis phenotypes. Osteoarthritis Cartilage 17, 321-327
Lee,C.W.,Hwang, I.,Park,C. S.,Lee,H.,Park,D.W.,Kang, S. J.,Lee, S. W., Kim, Y. H., Park, S. W., and Park, S. J. (2012) Expression of ADAMTS-2,-3,-13, and-14 inculprit coronary lesions inpatientswith acute myocardial infarction or stable angina. J. Thromb. Thrombolysis 33, 362-370
Jeltsch, M., Jha, S. K., Tvorogov, D., Anisimov, A., Leppänen, V. M., Holopainen, T., Kivelä, R., Ortega, S., Kärpanen, T., and Alitalo, K. (2014) CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation. Circulation 129, 1962-1971
Kleifeld,O.,Doucet, A., aufdemKeller, U., Prudova,A., Schilling, O., Kainthan, R. K., Starr, A. E., Foster, L. J., Kizhakkedathu, J. N., and Overall, C. M. (2010) Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat. Biotechnol. 28, 281-288
Prudova, A., auf dem Keller, U., Butler, G. S., and Overall, C. M. (2010) Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics. Mol. Cell. Proteomics 9, 894-911
Jefferson, T., Auf dem Keller, U., Bellac, C., Metz, V. V., Broder, C., Hedrich, J., Ohler, A., Maier, W., Magdolen, V., Sterchi, E., Bond, J. S., Jayakumar, A., Traupe, H., Chalaris, A., Rose-John, S., Pietrzik, C. U., Postina, R., Overall, C. M., and Becker-Pauly, C. (2013) The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin b and ADAM10. Cell. Mol. Life Sci. 70, 309-333
Fisher, L. W., Stubbs III, J. T., and Young, M. F. (1995) Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. Suppl. 266, 61-65
Moali, C., Font, B., Ruggiero, F., Eichenberger, D., Rousselle, P., François, V.,Oldberg, A., Bruckner-Tuderman,L., andHulmes, D. J. (2005) Substrate-specificmodulation of amultisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. J. Biol. Chem. 280, 24188-24194
Colige, A., Ruggiero, F., Vandenberghe, I., Dubail, J., Kesteloot, F., Van Beeumen, J., Beschin, A., Brys, L., Lapière, C.M., and Nusgens, B. (2005) Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V. J. Biol. Chem. 280, 34397-34408
Colige, A., Sieron, A. L., Li, S.W., Schwarze,U., Petty, E.,Wertelecki, W., Wilcox,W., Krakow, D., Cohn, D. H., Reardon,W., Byers, P. H., Lapière, C. M., Prockop, D. J., and Nusgens, B. V. (1999) Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am. J. Hum. Genet. 65, 308-317
Kleifeld, O., Doucet, A., Prudova, A., auf dem Keller, U., Gioia, M., Kizhakkedathu, J. N., and Overall, C. M. (2011) Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates. Nat. Protoc. 6, 1578-1611
Vizcaíno, J.A.,Deutsch,E.W.,Wang,R.,Csordas,A.,Reisinger,F.,Ríos, D.,Dianes, J.A.,Sun,Z.,Farrah,T.,Bandeira,N.,Binz,P.A.,Xenarios, I., Eisenacher,M.,Mayer,G., Gatto, L.,Campos,A.,Chalkley, R. J.,Kraus, H. J., Albar, J. P., Martinez-Bartolomé, S., Apweiler, R., Omenn, G. S., Martens,L., Jones,A.R.,andHermjakob,H. (2014)ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223-226
Auf dem Keller, U., and Overall, C. M. (2012) CLIPPER: an add-on to the Trans-Proteomic Pipeline for the automated analysis of TAILS N-terminomics data. Biol. Chem. 393, 1477-1483
Maere, S.,Heymans,K., andKuiper,M. (2005)BiNGO: aCytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448-3449
Doucet, A., and Overall, C.M. (2011) Broad coverage identification of multiple proteolytic cleavage site sequences in complex high molecular weight proteins using quantitative proteomics as a complement to edman sequencing. Mol. Cell. Proteomics 10, M110. 003533
Delolme, F.,Anastasi,C., Alcaraz, L.B.,Mendoza, V., Vadon-Le Goff, S., Talantikite,M., Capomaccio, R.,Mevaere, J., Fortin, L.,Mazzocut, D., Damour, O., Zanella-Cléon, I., Hulmes, D. J., Overall, C. M., Valcourt, U., Lopez-Casillas, F., and Moali, C. (2015) Proteolytic control ofTGF-b co-receptor activity byBMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics. Cell. Mol. Life Sci. 72, 1009-1027
Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J., and Gevaert, K. (2009) Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 6, 786-787
Lee, E. J., Jo, M., Rho, S. B., Park, K., Yoo, Y. N., Park, J., Chae, M., Zhang, W., and Lee, J. H. (2009) Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int. J. Cancer 124, 287-297
Romero, D., Kawano, Y., Bengoa, N., Walker, M. M., Maltry, N., Niehrs, C., Waxman, J., and Kypta, R. (2013) Downregulation of Dickkopf-3 disrupts prostate acinar morphogenesis through TGFb/Smad signalling. J. Cell Sci. 126, 1858-1867
Ge, G., and Greenspan, D. S. (2006) Developmental roles of the BMP1/TLD metalloproteinases. Birth Defects Res. C Embryo Today 78, 47-68
Fish, P. V., Allan, G. A., Bailey, S., Blagg, J., Butt, R., Collis, M. G., Greiling, D., James,K.,Kendall, J.,McElroy,A.,McCleverty,D.,Reed, C., Webster, R., and Whitlock, G. A. (2007) Potent and selective nonpeptidic inhibitors of procollagenC-proteinase. J.Med. Chem. 50, 3442-3456
Hulmes, D. J.,Mould,A. P., andKessler, E. (1997)TheCUBdomains of procollagen C-proteinase enhancer control collagen assembly solely by their effect on procollagen C-proteinase/bone morphogenetic protein-1. Matrix Biol. 16, 41-45
Das, D. S., Wadhwa, N., Kunj, N., Sarda, K., Pradhan, B. S., and Majumdar, S. S. (2013) Dickkopf homolog 3 (DKK3) plays a crucial role upstream of WNT/b-CATENIN signaling for Sertoli cell mediated regulation of spermatogenesis. PLoS One 8, e63603
Dubail, J., Kesteloot, F., Deroanne, C.,Motte, P., Lambert, V., Rakic, J. M., Lapière, C., Nusgens, B., and Colige, A. (2010) ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cell. Mol. Life Sci. 67, 4213-4232
Janssen, L.,Dupont, L., Bekhouche,M.,Noel, A., Leduc, C., Voz,M., Peers, B., Cataldo, D., Apte, S. S., Dubail, J., and Colige, A. (2016) ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis. Angiogenesis 19, 53-65
Maurer, L.M.,Tomasini-Johansson, B.R., andMosher, D. F. (2010) Emerging roles of fibronectin in thrombosis. Thromb. Res. 125, 287-291
Lohr, K. M., Kurth, C. A., Xie, D. L., Seyer, J.M., and Homandberg, G. A. (1990) The amino-terminal 29-and 72-Kd fragments of fibronectin mediate selective monocyte recruitment. Blood 76, 2117-2124
Kawano,Y., Kitaoka,M.,Hamada, Y.,Walker,M.M.,Waxman, J.,and Kypta, R. M. (2006) Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 25, 6528-6537
Sengle, G., Tsutsui, K., Keene, D. R., Tufa, S. F., Carlson, E. J., Charbonneau, N. L., Ono, R. N., Sasaki, T., Wirtz, M. K., Samples, J. R., Fessler, L. I., Fessler, J. H., Sekiguchi, K., Hayflick, S. J., and Sakai,L. Y. (2012)Microenvironmental regulationbyfibrillin-1. PLoS Genet. 8, e1002425
Bourd-Boittin, K., Bonnier, D., Leyme, A., Mari, B., Tuffery, P., Samson, M., Ezan, F., Baffet, G., and Theret, N. (2011) Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondintype 1motif, 1 as a central activator of transforming growth factor beta. Hepatology 54, 2173-2184
Kesteloot, F., Desmoulière, A., Leclercq, I., Thiry, M., Arrese, J. E., Prockop, D. J., Lapière, C. M., Nusgens, B. V., and Colige, A. (2007) ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride-induced hepatic fibrosis in mice. Hepatology 46, 1620-1631
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M., Lawler, J., Hynes, R. O., Boivin, G. P., and Bouck, N. (1998) Thrombospondin-1 is amajor activator of TGF-beta1 in vivo. Cell 93, 1159-1170
Murphy-Ullrich, J. E., and Poczatek, M. (2000) Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 11, 59-69
Esparza-Lopez, J.,Montiel, J. L., Vilchis-Landeros,M.M., Okadome, T., Miyazono, K., and López-Casillas, F. (2001) Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. J. Biol. Chem. 276, 14588-14596
López-Casillas, F., Wrana, J. L., and Massagué, J. (1993) Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73, 1435-1444
Velasco-Loyden, G., Arribas, J., and López-Casillas, F. (2004) The shedding of betaglycan is regulated by pervanadate andmediated by membrane type matrix metalloprotease-1. J. Biol. Chem. 279, 7721-7733
Boivin, W. A., Shackleford,M., Vanden Hoek, A., Zhao, H., Hackett, T. L., Knight, D. A., and Granville, D. J. (2012) Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-b1. PLoS One 7, e33163
Mendoza, V., Vilchis-Landeros, M. M., Mendoza-Hernández, G., Huang, T., Villarreal, M. M., Hinck, A. P., López-Casillas, F., and Montiel, J. L. (2009) Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor. Biochemistry 48, 11755-11765
Kirkbride,K.C.,Townsend,T.A.,Bruinsma,M.W.,Barnett, J.V., and Blobe, G. C. (2008) Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J. Biol. Chem. 283, 7628-7637
Wang,W.M., Lee, S., Steiglitz,B.M., Scott, I.C., Lebares,C.C.,Allen, M. L., Brenner, M. C., Takahara, K., and Greenspan, D. S. (2003) Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase. J. Biol. Chem. 278, 19549-19557
Verrecchia, F., and Mauviel, A. (2002) Transforming growth factorbeta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J. Invest. Dermatol. 118, 211-215
Verrecchia, F., and Mauviel, A. (2007) Transforming growth factorbeta and fibrosis. World J. Gastroenterol. 13, 3056-3062
